MétaCan
Menu
Back to cohort
Record W4413988428 · doi:10.1097/dcr.0000000000003946

Neoadjuvant Chemotherapy Without Radiation for Locally Advanced Rectal Cancer: A Meta-analysis of Surgical Outcomes After Total Mesorectal Excision

2025· article· en· W4413988428 on OpenAlexaff
Richard Garfinkle, Saba Balvardi, Marylise Boutros, Dean Fergusson

Bibliographic record

VenueDiseases of the Colon & Rectum · 2025
Typearticle
Languageen
FieldMedicine
TopicColorectal Cancer Surgical Treatments
Canadian institutionsOttawa HospitalUniversity of OttawaJewish General Hospital
Fundersnot available
KeywordsMedicineRandomized controlled trialMeta-analysisTotal mesorectal excisionColorectal cancerNeoadjuvant therapyChemotherapyRadiation therapySurgeryCochrane LibraryChemoradiotherapyCancerOncologyInternal medicineBreast cancer

Abstract

fetched live from OpenAlex

BACKGROUND: Neoadjuvant chemotherapy alone (with radiation omission) for locally advanced rectal cancer has been evaluated in several randomized controlled trials. Although oncologic outcomes have been well described, the impact of this treatment strategy on surgical outcomes is unknown. OBJECTIVE: To evaluate how important surgical outcomes were reported in previous trials comparing neoadjuvant chemotherapy to chemoradiation therapy for locally advanced rectal cancer and to perform a meta-analysis of available data. DATA SOURCES: A systematic review was conducted using MEDLINE, Embase, and the Cochrane Library Databases. STUDY SELECTION: All published randomized controlled trials that compared neoadjuvant chemotherapy to chemoradiation for MRI-staged rectal adenocarcinoma. INTERVENTIONS: Neoadjuvant chemotherapy alone (with radiation omission). MAIN OUTCOME MEASURES: Postoperative surgical outcomes, including anastomotic leak, diverting ostomy use, ostomy nonreversal, 30-day postoperative morbidity, and postoperative bowel function. RESULTS: Four randomized controlled trials met eligibility criteria and were included for data analysis. Oncologic outcomes demonstrated that neoadjuvant chemotherapy was equivalent or noninferior to chemoradiation therapy. Anastomotic leak and use of diverting ostomy were reported in 3 of the 4 trials, whereas 30-day postoperative morbidity and ostomy nonreversal were reported in only 2 trials. Bowel function was measured in 3 trials but was measured and reported differently in each trial. On meta-analysis, neoadjuvant chemotherapy was associated with a significant reduction in anastomotic leak (relative risk [RR] 0.54; 95% CI, 0.35-0.81), use of diverting ostomy (RR 0.79; 95% CI, 0.70-0.88), and ostomy nonreversal (RR 0.37; 95% CI, 0.15-0.93). There was no association between neoadjuvant chemotherapy and 30-day postoperative morbidity (RR 0.88; 95% CI, 0.53-1.45). LIMITATIONS: A small number of included trials with heterogeneity in outcome definitions was the limitation. CONCLUSIONS: Important surgical outcomes were not reported in trials comparing neoadjuvant chemotherapy alone to chemoradiation therapy for locally advanced rectal cancer. Based on the limited data available, chemotherapy alone was associated with reduced risk of anastomotic leak, diverting ostomy use, and ostomy nonreversal. See Video Abstract .

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.014
metaresearch head score (Gemma)0.028
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Meta-analysis · Consensus signal: Meta-analysis
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.014
Threshold uncertainty score0.074

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0140.028
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0140.054
Bibliometrics0.0040.004
Science and technology studies0.0010.001
Scholarly communication0.0030.001
Open science0.0020.001
Research integrity0.0020.002
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.017
GPT teacher head0.340
Teacher spread0.323 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designMeta-analysis
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations4
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueDiseases of the Colon & RectumSame topicColorectal Cancer Surgical TreatmentsFrench-language works237,207